Ihe na-egbochi eriri

Ihe na egbochi ihe eriri bụ ụdị ọgwụ ndị na-egbochi fibrinolysis. Ihe atụ gụnyere aminocaproic acid (ε-aminocaproic acid) na tranexamic acid. Ọgwụ ndị a yiri lysine na-egbochi mmepụta nke fibroid site na plasminogen ya site na plasmenogen activators (nke bụ isi t-PA na u-PA) nke na-ewere ọnọdụ karịsịa na mpaghara ndị nwere lysine n'elu fibrin.

Ihe atụ ọzọ ana akpọ protinin , bụ ihe na-egbochi protis dị iche iche na-eme n'okike; mba ụfọdụ jụrụ ịnakwere ọgwụ a n'ihi na a na-eche na ọ nwere ọnụọgụ ọnwụ karịa ndị ọzọ (tranexsmic acid na aminocaproic acid) ma na-emebi akụrụ na obi.^[1] A na-ekwenye n'ọtụtụ ebe na aga-ebelata iji aprotinin eme ihe n'ihi nchegbu ndị a.^[2]

Lekwaa

↑ Levy (March 2018). "Antifibrinolytic Therapy and Perioperative Considerations.". Anesthesiology 128 (3): 657–670. DOI:10.1097/ALN.0000000000001997. PMID 29200009.
↑ Aprotinin. European Medicines Agency (17 September 2018). Retrieved on 19 January 2023.

Njikọ ndị ọzọ

Anti fibrin optics at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
MeSH list of agents 82000933

Templeeti:Major drug groups

[1] Levy (March 2018). "Antifibrinolytic Therapy and Perioperative Considerations.". Anesthesiology 128 (3): 657–670. DOI:10.1097/ALN.0000000000001997. PMID 29200009.

[2] Aprotinin. European Medicines Agency (17 September 2018). Retrieved on 19 January 2023.

[1]

[2]